Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Mar;59(3):242-6.
doi: 10.1136/thx.2003.005876.

Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis

J Thornton  1 , R Elliott, M P Tully, M Dodd, A K Webb
Affiliations

Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis

J Thornton et al. Thorax. 2004 Mar.

Abstract

Background: Several studies have suggested that clinical outcomes in adults with cystic fibrosis (CF) are equivalent after home and hospital treatment with intravenous antibiotics, but these studies were small and selective and only considered one course of treatment.

Methods: A retrospective longitudinal study was performed to compare the clinical outcome over a period of 1 year of all patients attending the Manchester Adult CF Unit who received intravenous antibiotics at home or in hospital. The primary outcome measure was percentage change in forced expiratory volume in 1 second (FEV(1)) at the end of the 1 year period. Baseline "best" and "average" FEV(1) values were established for each patient for the year before the study. The secondary outcome measures were percentage changes in forced vital capacity (FVC) and body weight.

Results: A total of 116 patients received 454 courses of intravenous antibiotics. At the end of 1 year there had been a mean percentage decline in FEV(1) compared with the baseline "average" for patients treated mostly at home but an improvement in patients treated mostly in hospital (Tukey's HSD mean difference 10.1%, 95% CI 2.9 to 17.2, p = 0.003). For all patients there was a mean percentage decline in FEV(1) from the baseline "best" value. For each course of treatment the mean percentage improvements in FEV(1) at the end of the course from the start of the course were significantly higher for patients treated in hospital than for those treated at home.

Conclusions: Clinical outcome, as defined by spirometric parameters and body weight, was better after a course of treatment in hospital than after home treatment, and this benefit was maintained over 1 year of treatment. The results suggest that patients treated at home need closer supervision.

PubMed Disclaimer

References

    1. J R Soc Med. 2000;93 Suppl 38:2-8 - PubMed
    1. Ir J Med Sci. 1999 Jan-Mar;168(1):25-8 - PubMed
    1. Am Rev Respir Dis. 1983 Jun;127(6):725-34 - PubMed
    1. Lancet. 1984 Jun 16;1(8390):1338-9 - PubMed
    1. J Pediatr. 1987 Jul;111(1):28-33 - PubMed

Publication types

Substances